ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses

Yu, Hao; Li, Xing-Xiu; Han, Xing; Chen, Bin-Xin; Zhang, Xing-Hua; Gao, Shan; Xu, Dan-Qi; Wang, Yao; Gao, Zhan-Kui; Yu, Lei; Zhu, Song-Ling; Yao, Li-Chen; Liu, Gui-Rong*; Liu, Shu-Lin*; Mu, Xiao-Qin*哈尔滨医科大学
Frontiers in Microbiology2023-4-18DOI: 10.3389/fmicb.2023.1126808
9被引11阅读
引用收藏
分享

摘要

Many lines of evidence demonstrate the associations of colorectal cancer (CRC) with intestinal microbial dysbiosis. Recent reports have suggested that maintaining the homeostasis of microbiota and host might be beneficial to CRC patients, but the underlying mechanisms remain unclear. In this study, we established a CRC mouse model of microbial dysbiosis and evaluated the effects of fecal microbiota transplantation (FMT) on CRC progression. Azomethane and dextran sodium sulfate were used to induce CRC and microbial dysbiosis in mice. Intestinal microbes from healthy mice were transferred to CRC mice by enema. The vastly disordered gut microbiota of CRC mice was largely reversed by FMT. Intestinal microbiota from normal mice effectively suppressed cancer progression as assessed by measuring the diameter and number of cancerous foci and significantly prolonged survival of the CRC mice. In the intestine of mice that had received FMT, there were massive infiltration of immune cells, including CD8(+) T and CD49b(+) NK, which is able to directly kill cancer cells. Moreover, the accumulation of immunosuppressive cells, Foxp3(+) Treg cells, seen in the CRC mice was much reduced after FMT. Additionally, FMT regulated the expressions of inflammatory cytokines in CRC mice, including down-regulation of IL1a, IL6, IL12a, IL12b, IL17a, and elevation of IL10. These cytokines were positively correlated with Azospirillum_sp._47_25, Clostridium_sensu_stricto_1, the E. coli complex, Akkermansia, Turicibacter, and negatively correlated with Muribaculum, Anaeroplasma, Candidatus_Arthromitus, and Candidatus Saccharimonas. Furthermore, the repressed expressions of TGFb, STAT3 and elevated expressions of TNFa, IFNg, CXCR4 together promoted the anti-cancer efficacy. Their expressions were positively correlated with Odoribacter, Lachnospiraceae-UCG-006, Desulfovibrio, and negatively correlated with Alloprevotella, Ruminococcaceae UCG-014, Ruminiclostridium, Prevotellaceae UCG-001 and Oscillibacter. Our studies indicate that FMT inhibits the development of CRC by reversing gut microbial disorder, ameliorating excessive intestinal inflammation and cooperating with anti-cancer immune responses.

学科与关键词

关键词
colorectal cancerintestinal microbiotafecal microbiota transplantationinflammationanti-cancer immune responses
相关
加载中…
  • Role of microbes in colorectal cancer therapy: Cross-talk between the microbiome and tumor microenvironment
    Xia, Cong; Cai, Yantao; Ren, Shuangyi*; Xia, Chenglai*Frontiers in Pharmacology, 2022, 13: 1051330.被引 4
  • Gut microbiome in tumorigenesis and therapy of colorectal cancer
    Wang, Ling; Yu, Ke-Chun; Hou, Yun-qing; Guo, Min; Yao, Fan; Chen, Zhen-Xia*Journal of Cellular Physiology, 2023, 238(1): 94-108.被引 4
  • Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism
    Ou, Suwen; Wang, Hufei; Tao, Yangbao; Luo, Kangjia; Ye, Jinhua; Ran, Songlin; Guan, Zilong; Wang, Yuliuming; Hu, Hanqing; Huang, Rui*Frontiers in Cellular and Infection Microbiology, 2022, 12: 1020583.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Microbiology
发表日期
2023-04-18
卷期
第 14 卷
页码
1126808
DOI
10.3389/fmicb.2023.1126808
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [NSFC81903631, NSFC81971910, NSFC81871623, NSFC82020108022]; Youth Innovation Fund of University [UNPYSCT-2018065]; Postdoctoral Research Startup Fund of Heilongjiang Province [LBH-Q15080]

作者

  • Y

    Yu, Hao (第一作者)

    harbin med univ

  • L

    Li, Xing-Xiu

    harbin med univ

查看全部 15 位作者收起作者
  • H

    Han, Xing

    harbin med univ

  • C

    Chen, Bin-Xin

    harbin med univ

  • Z

    Zhang, Xing-Hua

    harbin med univ

  • G

    Gao, Shan

    2 · harbin med univ

  • X

    Xu, Dan-Qi

    harbin med univ

  • W

    Wang, Yao

    harbin med univ

  • G

    Gao, Zhan-Kui

    harbin med univ

  • Y

    Yu, Lei

    2 · harbin med univ

  • Z

    Zhu, Song-Ling

    harbin med univ

  • Y

    Yao, Li-Chen

    harbin med univ

  • L

    Liu, Gui-Rong (通讯)

    harbin med univ

  • L

    Liu, Shu-Lin (通讯)

    harbin med univ

  • M

    Mu, Xiao-Qin (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417